Iron Man: Novel Technologies for Autonomous Defense

Award Information
Agency:
Department of Defense
Branch
Defense Advanced Research Projects Agency
Amount:
$100,000.00
Award Year:
2009
Program:
STTR
Phase:
Phase I
Contract:
W911NF-09-C-0162
Award Id:
90054
Agency Tracking Number:
A09A-013-0259
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
278 DP Road, Suite D, Los Alamos, NM, 87544
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
147452275
Principal Investigator:
EvaBirnbaum
CSO
(505) 412-2345
eva@cpsci.com
Business Contact:
BenjaminWarner
CEO
(505) 412-2345
warner@cpsci.com
Research Institute:
Harvard Medical School
Nicole Touchet
25 Shattuck Street
Boston, MA, 2115
(617) 417-9622
Nonprofit college or university
Abstract
Caldera Pharmaceuticals proposes to develop a highly metal-selective system to maintain iron concentrations in the body at optimal levels to prevent infections. The system will control iron without the loss of other essential micronutrients; loss of micronutrients is the cause of toxicity in most chelation systems. Metal selectivity and the corresponding safety for use is the key difference between Caldera's system and other therapies. Caldera's XRpror will be used to conduct discovery-phase steps. Harvard collaborators will help to design and conduct a human study to determine whether optimal iron levels decrease spontaneous infection rates in a healthy population.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government